Recently, the U.S. Department of Health and Human Services finalized changes to confidentiality of alcohol and drug abuse patient records regulations (42 CFR Part 2) to facilitate health integration and information exchange among healthcare organizations while continuing to protect the privacy and confidentiality of patients. The updated law applies to all records related to the identity, diagnosis, prognosis or treatment of any patient in a substance abuse program that is conducted, regulated, or directly or indirectly assisted by any department or agency of the United States. Is your organization in compliance with the many requirements of this law?
The MHA Health Foundation webinar Confidentiality of Substance Use Disorder Patient Records: Complying with the New Federal Law will examine:
- Purpose of the new law
- Patient disclosure requirements and when it is prohibited to share patient information
- Facility obligations to patients for documenting disorder diagnosis, treatment and referral
- Patient access to medical records and restrictions on use
- Provisions for minor and deceased patients
- Security requirements for medical records
- Crimes on the premises and child abuse reporting
- Disclosures with and without consent
- Medical emergencies
- Complying with court orders
- How to correctly report violations or penalties to the law
Meet Your Faculty
Sue Dill Calloway, RN, MSN, JD, is a professional speaker and consultant and is president of Patient Safety and Health Care Education and Consulting, Dublin, OH. She is well-known nationwide for her work in healthcare law, risk management and patient safety.
Who Should Attend
Chief medical officers; directors of patient safety and risk management; compliance officers, hospital attorneys; personnel working in substance abuse departments
$195 per MHA member; $295 for non-MHA members
Members are encouraged to register by noon, May 15, 2017.
Printable Registration Form
For more information, click the contact button below.